Matthew Henn
Chief Scientific Officer
Other
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Seres Therapeutics, Inc. (MCRB) | President and Chief Scientific Officer | $489,300 | $1,014,347 |
| 2022 | Seres Therapeutics, Inc. (MCRB) | Executive Vice President and Chief Scientific Officer | $450,000 | $1,672,303 |
| 2021 | Seres Therapeutics, Inc. (MCRB) | Executive Vice President and Chief Scientific Officer | $430,000 | $3,551,792 |
| 2019 | Seres Therapeutics, Inc. (MCRB) | Executive Vice President and Chief Scientific Officer | $385,000 | $859,452 |
Earnings-call appearances
-
Seres Therapeutics, Inc. Q3 FY2025 Earnings Call2025-11-05
Seres Therapeutics, Inc. (MCRB)
-
Seres Therapeutics, Inc. Q2 FY2025 Earnings Call2025-08-06
Seres Therapeutics, Inc. (MCRB)
-
Seres Therapeutics, Inc. Q1 FY2025 Earnings Call2025-05-07
Seres Therapeutics, Inc. (MCRB)
-
Seres Therapeutics, Inc. Q2 FY2024 Earnings Call2024-08-13
Seres Therapeutics, Inc. (MCRB)
-
Seres Therapeutics, Inc. Q1 FY2024 Earnings Call2024-05-08
Seres Therapeutics, Inc. (MCRB)
-
Seres Therapeutics, Inc. Q4 FY2023 Earnings Call2024-03-05
Seres Therapeutics, Inc. (MCRB)
-
Seres Therapeutics, Inc. Q1 FY2023 Earnings Call2023-04-27
Seres Therapeutics, Inc. (MCRB)
-
Seres Therapeutics, Inc. Q4 FY2022 Earnings Call2023-03-07
Seres Therapeutics, Inc. (MCRB)
-
Seres Therapeutics, Inc. Q3 FY2022 Earnings Call2022-11-02
Seres Therapeutics, Inc. (MCRB)
-
Seres Therapeutics, Inc. Q2 FY2022 Earnings Call2022-08-03
Seres Therapeutics, Inc. (MCRB)
-
Seres Therapeutics, Inc. Q1 FY2022 Earnings Call2022-05-04
Seres Therapeutics, Inc. (MCRB)
-
Seres Therapeutics, Inc. Q4 FY2021 Earnings Call2022-03-01
Seres Therapeutics, Inc. (MCRB)
-
Seres Therapeutics, Inc. Q3 FY2021 Earnings Call2021-11-10
Seres Therapeutics, Inc. (MCRB)
-
Seres Therapeutics, Inc. Q1 FY2021 Earnings Call2021-05-04
Seres Therapeutics, Inc. (MCRB)
-
Seres Therapeutics, Inc. Q4 FY2020 Earnings Call2021-03-02
Seres Therapeutics, Inc. (MCRB)
-
Seres Therapeutics, Inc. Q3 FY2020 Earnings Call2020-09-30
Seres Therapeutics, Inc. (MCRB)
-
Seres Therapeutics, Inc. Q1 FY2020 Earnings Call2020-05-07
Seres Therapeutics, Inc. (MCRB)